Tenosynovial Giant Cell Tumor, Diffuse Type

Tenosynovial Giant Cell Tumor, Diffuse Type — Trials · CancerIndex

Clinical trials

Registered studies

15 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03069469	Study of Vimseltinib (DCC-3014) in Patients With Advanced Tumors and Tenosynovial Giant Cell Tumor	active not recruiting	Phase 1 / Phase 2	120	Deciphera Pharmaceuticals, LLCINDUSTRY	9	Jun 25, 2026	clinicaltrials
NCT05804045	Study of Pimicotinib (ABSK021) for Tenosynovial Giant Cell Tumor (MANEUVER)	active not recruiting	Phase 3	94	Abbisko Therapeutics Co, LtdINDUSTRY	7	May 4, 2026	clinicaltrials
NCT05059262	Study of Vimseltinib for Tenosynovial Giant Cell Tumor(MOTION)	active not recruiting	Phase 3	123	Deciphera Pharmaceuticals, LLCINDUSTRY	13	Mar 20, 2026	clinicaltrials

Data updated 22 days agoSource updated Jun 25, 2026source: clinicaltrials